Urologists 'Outraged' Over PSA Test Challenge
Siegel says he is concerned about "the greatest damage" the report will have on prostate screenings for African-American men, who are disproportionately affected by prostate cancer.
"I have been a urologist for almost 30 years. When I started training, 40% of African-American men at that time presented with metastatic disease. Now that number is miniscule," Siegel says. "Tell me how that happens without early screening? How do death rates go down from 48,000 when I trained to 28,000 now? How do you explain that without screening? You can't! It's impossible!"
Even though the test is being discouraged by the task force, Siegel says he believes many men and their physicians will want to keep the option on the table.
"If I am with a patient, I'm going to tell them 'we have a blood test to help diagnose prostate cancer. Yes, there are false positives. But if you have prostate cancer, do you want to know or do you want to play Russian roulette?'" he says. "Of course, I wouldn't say it like that. But that is the question. Who's going to say no?"
John Commins is a senior editor with HealthLeaders Media.
- Ratcheting Up Patient Experience Has a Downside
- 'Mega Boards' Could be Rural Healthcare Disruptor
- Narrow Networks Enjoying a Resurgence
- Physicians Trained in High-Cost Regions Spend More
- HL20: Anne Wojcicki—Unlocking Consumer Access to Genetics
- HL20: Lee Aase—Who's Behind @MayoClinic
- Christmas Tree Syndrome Season Underway
- HL20: Tom X. Lee, MD—Reinventing Primary Care
- Population Health Starts with Ending Hunger
- HL20: José Ramón Fernández-Peña, MD, MPA—A Welcoming Approach